Protalix BioTherapeutics (PLX) Net Equity Issued and Repurchased (2010 - 2026)
Protalix BioTherapeutics (PLX) recorded Net Equity Issued and Repurchased of $6.81 million in FY2025, up 87.9% from $3.63 million in FY2024.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Starting with FY2009, Protalix BioTherapeutics' Net Equity Issued and Repurchased history includes 14 years.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 7.0% (FY2020 to FY2025).
- Annual Net Equity Issued and Repurchased has ranged from $3.63 million in FY2024 to $23.95 million in FY2023 over the past five years.
- Per Business Quant data, PLX's Net Equity Issued and Repurchased was $3.63 million in FY2024 (-84.9%), $23.95 million in FY2023 (+190.8%), $8.24 million in FY2022 (-4.0%) and $8.58 million in FY2021 (+76.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.46 Bn | 1,099.05 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 635.24 Bn | 555.11 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 504.85 Bn | 477.96 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 358.66 Bn | 313.04 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 290.32 Bn | 254.31 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 265.28 Bn | 238.97 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 237.85 Bn | 193.25 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.96 Bn | 169.16 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 171.51 Bn | 118.16 Bn | 10.94 Bn | - |
| 10 | Protalix BioTherapeutics | 203.57 Mn | 52.18 Mn | 12.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 150,000.00 |
| Dec 31, 2025 | 146,000.00 |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 5.08 Mn |
| Jun 30, 2023 | 10.43 Mn |
| Mar 31, 2023 | 14.23 Mn |
| Dec 31, 2022 | 4.08 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Mar 31, 2021 | 46.20 Mn |
| Dec 31, 2020 | 4.87 Mn |
| Sep 30, 2020 | 4.47 Mn |
| Jun 30, 2020 | -1.26 Mn |
| Mar 31, 2020 | 38.61 Mn |
| Dec 31, 2016 | 14,000.00 |
| Dec 31, 2015 | 6.10 Mn |
| Mar 31, 2014 | 31,000.00 |
| Dec 31, 2013 | 82,000.00 |
| Jun 30, 2013 | 2,000.00 |
| Mar 31, 2013 | 28,000.00 |
| Dec 31, 2012 | 134,000.00 |
API Access
Protalix BioTherapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();